Is ChitogenX Inc. (CHNXF) a Buy, Sell, or Hold?
OTC : CHNXF
ChitogenX Inc.
$0.00755 USD
$0 (0.0%)
- Volume
- 50K
- Average Volume
- 41.67K
- Market Capitalization
- $627.63K
- P/E Ratio
- -0.23
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.02
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.07
Company Overview
OTC
Pierre Laurin
Biotechnology
Healthcare
CHNXF
5
CA
USD
Liquidity Metrics
-0.63
0.07
0.07
0.01
0.00
Sales & Valuation
-$
0.00
-0.06
-0.41
-0.01
Profitability
-$0.0213
-$1.55M
0.00%
0.00%
19.40%
-291.01%
P/E Metrics
-0.23
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-135.21
2/9
-$7.52M
$385K
$7.75M
-$1.25M
Key Metrics (TTM)
$4.26M
0.00
-6.35
0.07
19.40%
127.91%
-425.74%
-242.75%
-19041 days
Company Executives
| Name | Title |
|---|---|
| Guy-Paul Allard | Vice President of Legal Affairs & Corporate Secretary |
| Jonathan Sackier | Senior Vice President of Medical Affairs |
| Frédéric Dumais | Director of Communications & Investor Relations |
| Pierre Laurin | Interim Chief Executive Officer & Chairman |
| Benedek Simo | Controller |
| Luc Mainville | Senior Vice President & Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About ChitogenX Inc. (OTC:CHNXF) Stock
ChitogenX Inc. is a biologics firm focused on orthopedic and sports medicine, committing its efforts to pioneering novel soft tissue repair technologies. The company's primary objective is to elevate the efficacy of sports medicine surgical procedures through its research and development. Its developmental pipeline includes a range of specialized products: Ortho-R, a specific formulation designed for rotator cuff injuries; Ortho-M, a biopolymer addressing meniscus repair; Ortho-C, another biopolymer for the regeneration of articular cartilage; and Ortho-V, a biopolymer developed to facilitate the healing of osteoarthritis. Additionally, they are advancing ORTHO-T, a biopolymer formulation engineered for tendon healing and regeneration. Previously known as Ortho Regenerative Technologies In ... c., the company adopted its current name, ChitogenX Inc., in September of 2022. Established in 2015, ChitogenX maintains its headquarters in Kirkland, Canada.
Frequently Asked Questions
-
What is the current ChitogenX Inc. (CHNXF) stock price?
-
ChitogenX Inc.(OTC:CHNXF) stock price is $0.00755 in the last trading session. During the trading session, CHNXF stock reached the peak price of $0.0165 while $0.0011 was the lowest point it dropped to. The percentage change in CHNXF stock occurred in the recent session was 0.0% while the dollar amount for the price change in CHNXF stock was $0.
-
CHNXF's industry and sector of operation?
-
The OTC listed CHNXF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of CHNXF?
-
Guy-Paul Allard | Vice President of Legal Affairs & Corporate Secretary
Jonathan Sackier | Senior Vice President of Medical Affairs
Frédéric Dumais | Director of Communications & Investor Relations
Pierre Laurin | Interim Chief Executive Officer & Chairman
Benedek Simo | Controller -
How many employees does CHNXF have?
-
Number of CHNXF employees currently stands at 5. CHNXF operates from 16667 Hymus Boulevard, Kirkland, QC H9H 4R9, CA.
-
Link for CHNXF official website?
-
Official Website of CHNXF is: https://www.chitogenx.com
-
How do I contact CHNXF?
-
CHNXF could be contacted at phone #514-782-0951 and can also be accessed through its website. CHNXF operates from 16667 Hymus Boulevard, Kirkland, QC H9H 4R9, CA.
-
How many shares of CHNXF are traded daily?
-
The average number of CHNXF shares traded daily for last 3 months was 41.67K.
-
What is the market cap of CHNXF currently?
-
The market value of CHNXF currently stands at $627.63K with its latest stock price at $0.00755